There is a brief, awkward scene at the entrance to American healthcare. A person has chosen a provider, found an appointment and offered an insurance card. Then everyone waits for the machinery behind the card to explain itself. Is the coverage active? Is this provider in network? What will the visit cost? The questions sound ordinary. The answers travel through systems that are anything but.
Ashish Mandavia built a company around that pause. Sohar Health, which he co-founded with engineer Lucas Gordon in 2023, supplies the data plumbing for the opening minutes of a patient journey. Its software checks eligibility and benefits, identifies network status and helps calculate cost estimates. The interface is an API. The ambition is to make the answer arrive quickly enough that the waiting stops feeling like a separate stage of care.
It is a curious destination for a career that began in medicine. Mandavia trained at the University of Bristol, with an intercalated year studying medicine with management at Imperial College London, and worked as a doctor in the United Kingdom. Yet his route from clinic to company was less a leap than a sequence of adjacent rooms. He moved into product work, joined an early medical-education technology business, discovered the commercial side of building, led European operations at Pelago, and later advised digital-health companies at Simon-Kucher & Partners.
The useful detour
The résumé that reads backward
Seen one role at a time, Mandavia's career looks restless. Seen from Sohar, it looks like fieldwork. Clinical training taught him to make decisions amid incomplete information. Product management made him translate between a user's problem and an engineer's system. Commercial leadership exposed the actual routes by which buyers say yes, hesitate or disappear. Strategy consulting added the map: reimbursement, market access and the institutional logic around digital health.
This combination matters because insurance verification is not a single database lookup. Payers return information in inconsistent formats. Benefits can be carved out to other administrators. A provider can receive an answer that is technically present and practically useless. General-purpose tools may automate the request but still leave a team interpreting the reply. The founders' insight was that speed without domain-specific accuracy merely delivers confusion sooner.
Mandavia's range also made him a translator between tribes that share a building but not always a language. A clinician describes the consequence. An operations lead describes the queue. An engineer describes the constraint. A buyer describes the budget. Founders who hear only one of those accounts tend to build a polished fragment. His career supplied the full, occasionally contradictory transcript. Sohar could therefore begin with a workflow rather than a fashionable technology, then choose the tools that fit it. In a sector fond of acronyms, translation is infrastructure too.
“We believe in patients accessing healthcare without limits.”Ashish Mandavia and Lucas Gordon, on Sohar's long-term vision
Mandavia had already watched those integration problems slow people down at Pelago, then known as Quit Genius. Gordon had been the company's CTO and had built connections across employers and health plans. Their skills overlapped around one stubborn problem from opposite directions: Mandavia understood the clinical and commercial stakes; Gordon understood the systems.
A company begins during leave
At the start of 2023, Gordon had left Pelago and Mandavia was on paternity leave from his consulting job. They caught up. The payer problem resurfaced, as durable annoyances tend to do. Their first idea centered on employer eligibility for digital-health companies. Customer conversations quickly pointed toward a wider and more immediate knot: real-time eligibility and coverage-of-benefits work for providers.
That shift is the founding story's useful detail. They did not fall in love with the first framing. They followed the pain toward the people doing the work. A pre-seed round led by Concept Ventures gave them room to build. Later that year Sohar joined Y Combinator's Summer 2023 batch. The founders have said those ten weeks pulled the company roughly twelve months forward, partly through the accelerator's cadence of guidance and peer accountability.
The accelerator did something else useful: it forced an infrastructure company to describe itself in human terms. Sohar's pitch was not “better middleware.” It was fewer preventable denials, less manual interpretation and a smoother route through the front door. The company's public product figures put the median response at six seconds, with more than 90 percent of checks returned within 30 seconds and eligibility determination reported at 99 percent accuracy.
What the product promises to remove
Numbers from a company's own product profile should be read as operating claims, not laws of nature. Still, they reveal how Mandavia frames the work. Accuracy comes first. Latency comes next. Then automation. In an industry easily distracted by dazzling demonstrations, Sohar's scorecard is almost sternly practical. Did the right answer arrive, did it arrive in time, and did a person need to rescue it?
The glamour of plumbing
Founders often speak of platforms when they mean products with ambitions. Sohar means the plumbing. The company integrates into other organizations' intake and revenue workflows, beneath the page a patient sees. Its customers and partners have included names such as Talkiatry, Rula and Zocdoc. Success is deliberately quiet: fewer confused handoffs, fewer manual checks and fewer reasons for an appointment to stall at the beginning.
In March 2025, the company raised a $3.8 million seed round led by Kindred Capital, with Concept Ventures, Rebel Fund and Y Combinator participating. The money was assigned to expanding its AI-driven verification work. Later that year, Mandavia appeared on Becker's Healthcare's list of Health IT and Revenue Cycle Up-and-Comers, while Sohar was selected for CB Insights' Digital Health 50 in the revenue-cycle-management category.
The recognitions are useful signals, though Mandavia's more revealing public habit is teaching. He has written about structured thinking since his early career, comparing the reasoning of doctors and consultants. He mentors clinicians hoping to enter health tech. On podcasts he returns to the same hinge ideas: automation needs transparency, infrastructure has to earn trust, and technology must meet the workflow as it exists.
The operating doctrine
Accuracy before theater. An elegant answer is worthless if it is wrong.
Translate the edge cases. The hard part is often not sending a request but interpreting what comes back.
Follow the tolerated friction. Repeated manual work is a map of where software has not finished the job.
A diagnostic temperament
There is a physician's rhythm to this operating doctrine. Observe. Separate symptom from cause. Structure the uncertainty. Choose an intervention and measure what changed. Mandavia's old essays about diagnostic thinking now read like accidental founder notes. The white coat is gone, but the method survived the wardrobe change.
Colleagues have publicly described him as persistent in ambiguous environments and credited him with building Pelago's EMEA business. Sohar's own portrait adds less corporate details. He supports Liverpool FC. He learned to make pasta from scratch during lockdown. He visits Gordon in Dubai, sometimes with his family, and seems partial to turning conference networking into coffee, a breakfast burrito or a walk. These details matter because infrastructure founders can otherwise sound like their databases: efficient, serious and strangely without hobbies.
By 2026, the company's language had widened from insurance verification to the infrastructure layer for front-end revenue-cycle work. New products covered network status and cost estimates. Mandavia's conference appearances focused on connected systems and workflow orchestration. Sohar was no longer describing a single useful check. It was describing the sequence of answers a provider needs before the visit begins.
Good infrastructure does not ask to be admired. It asks to be trusted, then gets out of the way.
That is also a direct reading of Mandavia's aspiration. The company wants to make healthcare's front door feel less like a locked filing cabinet and more like a modern transaction: fast, legible and unsurprising. The work is detailed. Payer by payer, field by field, exception by exception. Oscar Wilde never wrote an epigram about eligibility data, which is perhaps proof that civilization has left a few essential jobs to the rest of us.
Sohar remains a young company, and infrastructure earns its reputation slowly. Yet Mandavia's path offers one durable lesson before the verdict arrives. A career need not advance in a straight line to compound. Medicine, product, sales and consulting gave him four vocabularies for one system. The company appeared when he and Gordon finally used them in the same conversation.
And so the story returns to that six-second pause. A card is handed over. A question crosses a network. Somewhere underneath the appointment form, an API tries to make the complicated machinery behave like a simple answer. If it works, nobody celebrates. They simply move forward. For Ashish Mandavia, that ordinary motion is the point.